Atlantic Street Capital (ASC), a private equity firm that invests in lower middle market companies to unlock equity value through an operationally intensive investment approach, is to sell Advancing Eyecare, North America’s leading provider of ophthalmic instruments, to Cornell Capital.
Advancing Eyecare was formed in 2019 when ASC combined its 2016 portfolio company investment in Lombart Instrument, the leading US distributor of ophthalmic instruments to ophthalmologists and optometrists, with Marco Ophthalmic Inc, a market leading, high-tech instrumentation supplier.
The transaction, which is subject to customary closing conditions, is expected to be completed in the second quarter of 2022.
